BaseSpace
Correlation
Engine-Public
Sign In
Register
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
BRAF
,
Metabolism of xenobiotics
,
Breast Cancer
,
Stem cell
,
Amniocentesis
,
Doxycycline
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
head and neck squamous cell carcinoma
(phenotype)
Summary
General Info
Genetic Markers
Most Correlated Genes
Most Correlated SNPs
MMP1
HTN3
CYP4F29P
PADI1
RAC1P2
No SNPs found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
response to stress
DODD_NASOPHARYNGEAL_CARCINOMA_DN
heterocyclic compound binding
response to organic substance
regulation of nitrogen compound metabolic process
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Tumor invasion in Oral Squamous Cell Carcinoma
Squamous cell carcinoma of oral cavity with lymph node metastasis
Oral squamous cell carcinoma compared to normal tongue
Gene expression profiling of oral squamous cell carcinoma
Nasopharyngeal carcinoma SUNE1 cells with WIPI-1 shRNA knockdown
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for head and neck squamous cell carcinoma
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Neoadjuvant Adebrelimab Plus Dalpiciclib in Head and Neck Squamous Cell Carcinoma
Reduction of Postoperative Radiotherapy in Head and Neck Squamous Cell Carcinoma
Pembrolizumab, INCB081776, and Radiation Therapy for Head and Neck Squamous Cell Carcinoma
Rapamycin Therapy in Head and Neck Squamous Cell Carcinoma
Neoadjuvant Camrelizumab With Dalpiciclib for Resectable Head and Neck Squamous Cell Carcinomas
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ